Avista Healthcare Partners Announces Promotions
Avista Healthcare Partners (ORGO) announced on January 5, 2026 three promotions within its investment team: Ryan Moran and Garrett Lustig were promoted to Partner, and Elaine Tang was promoted to Principal.
Rhea-AI Summary
Avista Healthcare Partners (ORGO) announced on January 5, 2026 three promotions within its investment team: Ryan Moran and Garrett Lustig were promoted to Partner, and Elaine Tang was promoted to Principal.
The announcement highlights each executive's tenure and background: Moran joined Avista in 2018 with prior roles at Morgan Stanley Capital Partners and Bank of America Merrill Lynch; Lustig joined in 2015 from Centerview Partners; Tang joined in 2022 from Partners Group. Each exec currently serves on multiple portfolio company boards, including Organogenesis (Nasdaq: ORGO) for Lustig.
David Burgstahler, CEO, said the promotions reflect Avista's growth and focus on developing leadership as the firm pursues healthcare investment opportunities.
Positive
- None.
Negative
- None.
Details
News Market Reaction – ORGO
In the Jan 5 session, ORGO declined 4.85%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Promotion count
- 3 promotions
- Three Avista investment professionals elevated (two to Partner, one to Principal)
- Ryan Moran tenure
- Joined 2018
- Year Ryan Moran joined Avista before promotion to Partner
- Garrett Lustig tenure
- Joined 2015
- Year Garrett Lustig joined Avista before promotion to Partner
- Elaine Tang tenure
- Joined 2022
- Year Elaine Tang joined Avista before promotion to Principal
Historical Context
-
Rolling BLA submission for ReNu with final modules expected in 1H 2026.
-
Successful FDA Type-B meeting and plan to initiate rolling BLA for ReNu.
-
Record Q3 revenue, higher profitability, and raised FY2025 revenue and EBITDA guidance.
-
CMS finalized skin substitute payment reform viewed as supportive for PMA products.
-
Inducement stock options and RSUs granted to new CTO under Nasdaq Rule 5635(c)(4).
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Ryan Moran has been promoted to Partner;
- Garrett Lustig has been promoted to Partner; and
- Elaine Tang has been promoted to Principal.
David Burgstahler, Managing Partner and Chief Executive Officer of Avista, commented:
"We are thrilled to recognize Ryan, Garrett, and Elaine for their outstanding contributions to Avista's success as well as their partnerships with our portfolio company management teams and Boards. The firm's growth and continued development of our team underscore the depth and strength of the firm's leadership team. We look forward to their leadership as we pursue new and compelling investment opportunities in the healthcare sector."
Ryan Moran: Ryan joined Avista in 2018. Prior to joining Avista, he was an Associate at Morgan Stanley Capital Partners where he focused on private equity investments across a range of industries. Prior to joining Morgan Stanley, he worked as an Analyst in the investment banking division at Bank of America Merrill Lynch. Ryan received a B.A. from The George Washington University and an M.B.A. from Harvard Business School. He currently serves as a Director of Cosette Pharmaceuticals, GCM Holding Corporation, WellSpring Consumer Healthcare, and XIFIN.
Garrett Lustig: Garrett joined Avista in 2015. Prior to joining Avista, he worked in investment banking at Centerview Partners. Garrett received a B.S. from Duke University. He currently serves as a Director of ACP Northern Holdings, EBi Bone Healing, eMolecules, Organogenesis (Nasdaq: ORGO), Taconic Biosciences, and Terrats Medical and previously served as a Director of Solmetex, Spear Education, United BioSource Corporation, and XIFIN.
Elaine Tang: Elaine joined Avista in 2022. Prior to joining Avista, she worked in private equity at Partners Group. Elaine received a B.A. from Wellesley College and an M.B.A. from Harvard Business School. She currently serves as a Director of PK Benelux and Probo Medical.
About Avista Healthcare Partners
Avista Healthcare Partners, founded in 2005 by Thompson Dean and David Burgstahler, is a leading New York-based private equity firm with over
For media inquiries, please contact:
Daniel Yunger / James Lindsay
Kekst CNC
daniel.yunger@kekstcnc.com / james.lindsay@kekstcnc.com
917.574.8582 / 917.842.4119
View original content:https://www.prnewswire.com/news-releases/avista-healthcare-partners-announces-promotions-302652569.html
SOURCE Avista Healthcare Partners
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.